Population genomic datasets describing the post-vaccine evolutionary epidemiology of Streptococcus pneumoniae. by Croucher, NJ et al.
Population genomic datasets
describing the post-vaccine
evolutionary epidemiology of
Streptococcus pneumoniae
Nicholas J. Croucher1, Jonathan A. Finkelstein2,3, Stephen I. Pelton4, Julian Parkhill5,
Stephen D. Bentley5, Marc Lipsitch6 & William P. Hanage6
Streptococcus pneumoniae is common nasopharyngeal commensal bacterium and important human
pathogen. Vaccines against a subset of pneumococcal antigenic diversity have reduced rates of disease,
without changing the frequency of asymptomatic carriage, through altering the bacterial population
structure. These changes can be studied in detail through using genome sequencing to characterise
systematically-sampled collections of carried S. pneumoniae. This dataset consists of 616 annotated draft
genomes of isolates collected from children during routine visits to primary care physicians in
Massachusetts between 2001, shortly after the seven valent polysaccharide conjugate vaccine was
introduced, and 2007. Also made available are a core genome alignment and phylogeny describing the
overall population structure, clusters of orthologous protein sequences, software for inferring serotype from
Illumina reads, and whole genome alignments for the analysis of closely-related sets of pneumococci. These
data can be used to study both bacterial evolution and the epidemiology of a pathogen population under
selection from vaccine-induced immunity.
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Background & Summary
Streptococcus pneumoniae (the pneumococcus) is a genetically diverse bacterial species commonly
asymptomatically carried in the nasopharynx of infants, an age group not capable of generating a strong
adaptive immune response to the polysaccharide capsule that envelopes most pneumococcal cells1. This
capsule inhibits immune clearance by both complement- and neutrophil-mediated pathways2, and is a
critical factor in allowing S. pneumoniae to invade other anatomical sites and cause disease such as
pneumonia, bacteraemia and meningitis, particularly in both the young and elderly. Consequently,
polysaccharide conjugate vaccines (PCVs) based on the pneumococcal capsule have been developed to
induce anti-pneumococcal immunity in children3. These vaccine formulations are limited in the number
of antigens they contain: the ﬁrst licensed formulation (PCV7) contained seven serotypes. However, over
90 immunologically distinct capsule polysaccharides (serotypes) have been identiﬁed in S. pneumoniae4,
which is the consequence of extensive genetic variation at the capsule polysaccharide synthesis (cps)
locus. Hence at the point of vaccine introduction the pneumococcal population consists of a mix of
‘vaccine serotypes’, susceptible to artiﬁcially-induced host immunity, and ‘non-vaccine serotypes’.
Nevertheless, the widespread use of PCVs has caused a substantial fall in the incidence of invasive
pneumococcal disease5.
This is the consequence of the PCV7 vaccine having at least 50% efﬁcacy in preventing
nasopharyngeal carriage of vaccine serotypes6,7, and around 98% (ref. 8) efﬁcacy against invasive disease
caused by the same types. However, the overall levels of pneumococcal carriage have not changed post-
vaccination owing to serotype replacement9,10: the increase in frequency of non-vaccine serotypes. The
reduced incidence of pneumococcal disease has therefore been attributed to the lower rate at which these
non-vaccine serotypes cause symptomatic infections relative to vaccine serotypes11. Additionally, as many
multidrug-resistant pneumococci were of PCV7 serotypes prior to the vaccine’s introduction, it was
anticipated that PCV7 would decrease the levels of S. pneumoniae antimicrobial resistance; however, any
such beneﬁt in this regard observed shortly after vaccine introduction12 was not sustained over the longer
term13. Hence understanding how the carried pneumococcal population structure changes following the
implementation of partial coverage PCVs is important for relating the intervention to its subsequent
clinical outcomes.
To address this question, the carried population of pneumococci in Massachusetts has been followed
by the Streptococcus pneumoniae Antimicrobial Resistance in Children (SPARC) project. The instigation
of this study coincided with the introduction of PCV7 in the USA in 2000. Samples were obtained
through swabbing the nasopharynx of children seven years of age or under during routine visits to
primary care physicians14. In the spring of 2001, winter and spring of 2004, and winter and spring of
2006–2007, 742, 994 and 972 individuals were sampled, respectively13–15. The detected level of
pneumococcal colonisation remained stable over these winters, with 190 (26% prevalence), 232 (23%
prevalence) and 294 (30% prevalence) S. pneumoniae isolates recovered in the three successive sampling
periods. This collection has been used to analyse the changing antigenic proﬁle of the population in
response to vaccine-induced immunity through serological typing13–15. The same collection was also
genotyped by multilocus sequence typing16 (MLST) to relate these changes to the elimination, emergence
and diversiﬁcation of individual bacterial lineages17,18. Subsequently, whole genome sequencing was
applied to the collection to investigate the population dynamics in greater detail19. This dataset consists of
616 annotated draft S. pneumoniae genomes representing the evolutionary epidemiology of the species as
the population structure changed in response to vaccine-induced selection pressures. To aid analysis of
the overall set of isolates, the species-wide core genome alignment and phylogeny are also made available,
as are the predicted protein sequences, a method for inferring serotype from Illumina reads, and whole
genome alignments for ﬁfteen sets of closely-related isolates.
Methods
Culturing and phenotyping of strains
Following retrieval from storage, all bacterial samples were colony puriﬁed, then grown on 5% sheep’s
blood agar overnight at 37 °C in the presence of 5% CO2. Samples were serologically typed using latex
agglutination (Statens Serum Institut, Copenhagen) as a check on sample handling. Discrepant results
with previous typing were veriﬁed using the Quellung reaction (Statens Serum Institut, Copenhagen;
Table 1 (available online only)).
Overnight plate growth was harvested through resuspension in phosphate buffered saline, and
genomic DNA was extracted using DNeasy columns (Qiagen) following manufacturer’s instructions. The
concentration of genomic DNA was quantiﬁed using the Qubit system (Life Technologies); all samples
yielded at least 3 μg of DNA. The integrity of the genomic DNA was checked using agarose gel
electrophoresis relative to a λHindIII ladder (New England Biolabs).
Generation of sequence data
Illumina sequencing libraries were constructed as described previously20,21. Brieﬂy, genomic DNA was
ﬁrst fragmented using Adaptive Focused Acoustics technology (Covaris). The resulting fragments were
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then repaired to ensure they had blunt ends, phosphorylated at their 5′ end, A-tailed at the 3′ end, and
ligated to adapter molecules. This library of fragments was then separated by agarose gel electrophoresis.
DNA constructs of the appropriate size range (generating an insert size of approximately 150–300 bp)
were then extracted from the gel and ampliﬁed by a polymerase chain reaction using Kapa HiFi
polymerase (Kapa Biosystems) that added one of the 96 index tags used in this project. Libraries were
then quantiﬁed using qPCR, and combined into an equimolar pool of 96 samples prior to denaturation,
cluster generation and sequencing in a single ﬂow cell lane with an Illumina HiSeq machine. Isolates from
2001 and 2003–2004 were sequenced as paired end libraries generating 75 nt reads; isolates from
2006–2007 were sequenced as paired end libraries generating 100 nt reads.
Assembly and annotation of sequence data
Sequences were assembled de novo using Velvet22 version 1.2 with parameters selected to be optimal for
individual datasets as described previously23. Both Glimmer3 (ref. 24) and Prodigal25 were trained on the
reference sequence of S. pneumoniae ATCC 700669 (ref. 26; Data Citation 1), then applied to the
complete draft assembly with an 11 nt sequence encoding stop codons in each reading frame added to
each end, to facilitate the identiﬁcation of partial coding sequences (CDSs) broken by the assembly.
Putative CDSs were then trimmed at the 3′ end to stop them spanning contig breaks within the assembly.
Final CDS predictions were identiﬁed as the consensus of Glimmer3 and Prodigal outputs, as described
previously19 (Table 1 (available online only)). Protein sequences were then translated, aligned using
BLAT27 suite 0.34, and ‘clusters of orthologous genes’ (COGs) identiﬁed using COGsoft28. Pairs of
orthologous sequences were then manually identiﬁed as described previously19.
To generate functional annotations of genome sequences, all CDSs were labelled with a unique
identiﬁer (of the form, ‘ERSX_Y’, where ‘ERSX’ is the sample accession code in the European Nucleotide
Archive listed in Table 1 (available online only) and Y is an incrementing index) and their COG (of the
form, ‘SPARC1_CLSZ’ or ‘SPARC1_CLSTZ’, where Z is a number). COGs relating to antibiotic resistance
and the newly-characterised variable restriction-modiﬁcation system loci were annotated as described
previously29; the 590 COGs found to be speciﬁc to prophage, the three COGs found to be speciﬁc to a
particular prophage remnant, the 142 COGs found to be speciﬁc to phage-related chromosomal islands,
and the 355 COGs found to be speciﬁc to integrative and conjugative elements were also appropriately
identiﬁed in these datasets29. All COGs not belonging to one of these categories were annotated using a
database of pneumococcal CDS information. This was constructed by extracting the protein sequences
and annotated functions from publicly-available complete genomes and the annotation of 90 capsule
polysaccharide synthesis loci30. Where a CDS in one of the draft genomes had a putative protein sequence
identical to the translated sequence of a previously annotated locus, the annotation was directly
transferred; otherwise, the annotation was transferred on the basis of orthology, if another putative
protein in the same COG was identical to the translation of a CDS in an annotated genome sequence. In
cases where no such information could be obtained, CDSs were labelled as producing ‘hypothetical
proteins’. Pneumococcal small interspersed repeats were annotated as described previously31, and tRNA
and rRNA loci were annotated with tRNAscan-SE32 version 1.3.1 and rnammer33 version 1.2, respectively
(Table 1 (available online only)).
Generation of core genome alignment and overall phylogeny
As described previously19, the 1,194 COGs found to have a single representative in each of the 616 genomes
were individually aligned at the protein level using MUSCLE34, prior to backtranslation to generate a
1.14Mb codon alignment. The 106,196 polymorphic sites were extracted and used to generate a phylogeny
using RAxML35 version 7.0.4 with the general time reversible substitution model and a four category
gamma distribution to account for rate heterogeneity. This tree was midpoint rooted on the longest branch,
which separated sequence cluster 12 from the rest of the population. This is consistent with a wider
phylogenetic analysis of multiple species that suggested sequence cluster 12 was the earliest lineage to
diverge from the other isolates19. The same alignment was analysed with BAPS36 version 5 to identify the
sequence clusters. Both the core genome alignment and tree are made available as part of Data Citation 2.
Generation of whole genome alignments
For each of the ﬁfteen monophyletic sequence clusters identiﬁed using BAPS and RAxML, a single
reference draft assembly was selected for manual curation. The Illumina read data were reassembled with
SGA37 version 0.9, and these contigs merged with those from Velvet using Zorro38 version 2.2. These
were arranged into scaffolds using SSPACE39 version 2, then manually curated and ordered using
ABACAS40 and ACT41. These ﬁfteen assemblies are made available as part of Data Citation 2. Illumina
read pairs from isolates of the same sequence cluster were then mapped against this reference using
SMALT42 version 0.5.8. The resulting read alignment was processed with Samtools43, VCFtools44 and
Biopython45 to generate a consensus sequence. Bases were called at positions spanned by at least two
reads in each direction, where at least a 75% consensus on the allele was evident; additionally, the base
quality at the site had to be at least 50, and the mapping quality had to be at least 30, on the Phred
scale46,47. These consensus sequences from each representative of the sequence cluster were then
combined to generate a reference-based multiple genome alignment, each of which was analysed as
described previously using an earlier version of the Gubbins48 software. These ﬁfteen whole genome
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alignments, which do not include the reference assemblies themselves, are also made available as part of
Data Citation 2.
Code Availability
The algorithm used to predict recombination events has been developed into a software package, named
Gubbins48, which can be installed on Linux and Max OSX operating systems. It can also be run
on Windows operating systems using a virtual machine environment, and is freely available from
http://sanger-pathogens.github.io/gubbins/. Code and reference sequences for the serological typing of
S. pneumoniae using sequence reads is made available as part of Data Citation 2.
Data Records
The raw sequence data (FASTQ format) and annotated draft genome sequences (EMBL format) for the
616 isolates in the dataset have been deposited in the European Nucleotide Archive (http://www.ebi.ac.
uk/ena/) with the project accession code in Data Citation 3. Individual accession codes for both raw read
data and annotated draft genome assemblies are listed in Table 1 (available online only) and in the
machine-readable ISA-tab metadata ﬁles associated with this article.
Further ﬁles are made available through the Dryad repository (https://datadryad.org) with the digital
object identiﬁer in Data Citation 2. The core genome codon alignment (FASTA format) and maximum
likelihood phylogeny (Newick format) describe the overall population structure. For the study of
individual lineages, a whole genome alignment (FASTA format) and draft reference assembly (FASTA
format) are included for each of the 15 monophyletic sequence clusters19. These encompass 491 of the
isolates, excluding those in the diverse polyphyletic sequence cluster 16. In addition, the full set of protein
coding sequences (FASTA format), and the translated proteins (FASTA format), can be used to study the
diversity of individual COGs. To minimise the manipulation of the protein sequences, the initial amino
acid of each protein is directly translated, rather than being converted to a methionine.
The epidemiological and phylogenetic data can also be interactively visualised and analysed online
using the Microreact website (http://microreact.org/) with the URL in Data Citation 4.
Technical Validation
Integrity of sample handling and quality control
An overview of the processing pipeline, including the technical validation steps, is shown in Fig. 1. Of the
716 samples collected as part of the surveillance project between 2001 and 2007, 631 could be revived and
cultured. All these isolates were subjected to serological typing using latex agglutination to ensure
consistency of sample handling relative to previous studies (Fig. 1 and Table 1 (available online only)). As
multiple colonisation is often observed in children49 it was not necessarily expected that the original
strain would be recovered in all cases; in the earlier studies, only a single isolate per individual was
analysed in order to maximise the size of the host population sample, as detecting strains carried at low
frequencies is inefﬁcient using standard microbiological techniques50. The serology differed from that
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Figure 1. Workﬂow for the generation of draft genome assemblies. The ﬂow chart shows the steps taken to
generate the draft genome dataset; boxes in orange indicate steps at which typing was performed, allowing the
integrity of sample handling to be checked, and boxes in blue indicate steps at which checks were performed to
allow for the identiﬁcation and elimination of low quality samples.
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previously recorded for 12 of the 631 samples. These new serotype inferences were all independently
veriﬁed as being correct using a second culture of the same isolate, and subsequently conﬁrmed in all
seven cases where the samples were retyped in a separate laboratory using the Quellung reaction51. One
sample yielded two clearly morphologically distinct strains that proved to be of different serotypes,
increasing the number of isolates in the study to 632. All isolates found to be non-typeable serologically
were tested for optochin susceptibility using ‘P discs’; this identiﬁed one isolate as likely to represent a
non-pneumococcal streptococcus, the exclusion of which reduced the overall collection size to 631.
Sufﬁcient high-quality genomic DNA for analysis was extracted from all isolates. After sequencing,
nine samples failed either automated quality control checks implemented by the Sanger Institute, or
manual investigation of dataset properties, such as adapter content, insert size and GC content; one of
these failures was successfully resequenced. After assembly of the remaining 623 samples, seven further
samples were rejected as generating low quality draft genomes. These represented cases where the N50
was below 15 kb and the total assembly length was greater than 2.4 Mb, likely as a consequence of
sequence from more than one isolate being mixed in the raw Illumina reads. This resulted in the ﬁnal
dataset of 616 draft genomes.
Integrity of data handling
Serotypes and multilocus sequence types (STs) were inferred from Illumina read data as described
previously23. Excluding isolates determined as being ‘non typeable’ by either microbiological or
bioinformatic serotyping, across the ﬁnal set of 616 samples the capsule polysaccharide synthesis (cps)
locus was congruent with the serogroup (a set of antigenically similar serotypes) identiﬁed through
immunological tests in all but two cases. Of the 594 isolates for which an ST had been previously
established, 553 (93%) were identical with those inferred from Illumina reads (Fig. 2a). These included
both cases where the genome’s cps locus did not match the experimentally ascertained serogroup,
indicating these discrepancies were not likely to result from sampling handling issues. Of the 41 cases in
which the original ST was discrepant with that inferred from the reads, 29 differed at only one of the
seven loci (Fig. 2b). All remaining inconsistencies are likely to reﬂect instances of multiple colonisation,
resulting in different strains being originally genotyped before storage and subsequently retrieved for
sequencing. This is consistent with the cps locus from the sequence reads in these cases matching the
serology of the revived isolates from which the genomic DNA was extracted.
Quality of genome assemblies
The 616 samples in the dataset each yielded between 267 and 1,865 Mb of sequence data (median of
652 Mb). Assuming a typical 2 Mb S. pneumoniae genome26, this meant each isolate had a sequencing
depth of over 100 fold coverage. Based on a random sample of 10,000 reads aligned to a set of prokaryotic
and eukaryotic reference genomes using BWA52, a substantial majority of reads matched to the
S. pneumoniae representative (strain ATCC 700669) in each dataset, conﬁrming these data were
primarily derived from the submitted genomic DNA sample.
All draft assemblies had an N50 greater than 15 kb and a total length between 1.98 and 2.19 Mb,
similar to complete S. pneumoniae genomes. Additionally, the number of CDSs in the de novo assemblies
was within the range of CDSs found within annotated complete or high-quality draft S. pneumoniae
genomes (Fig. 2c,d). Each isolate’s annotation included at least 101 of the 102 protein functional domains
recently suggested to be essential and ubiquitous across cellular genomes53; the only discrepancy was the
short ribosomal protein coding sequence rpsN, which was not consistently identiﬁed by the automated
gene annotation software even when present within assemblies. Assembly quality was also judged on the
basis of non-coding RNA content: using previously-deﬁned criteria53, the majority of isolates had a full-
length representative of each of the ribosomal RNAs. Similarly, quantifying tRNA content found the
majority of isolates had at least one tRNA for each standard amino acid.
To ascertain the accuracy of the de novo assemblies relative to the original epidemiological data and
Illumina sequence reads, the STs were extracted from the contigs through identiﬁcation of the relevant
loci using BLAST54 (Fig. 2a,b). All seven loci could be recovered from each assembly. Across the 616
samples, the ST extracted from the assembly and Illumina reads was identical in 602 cases (98%
accuracy). In four cases, the ST inferred from the assemblies differed from the consensus of the original
genotyping and the ST extracted from the reads at a single locus (Fig. 2a). In six cases, the ST inferred
from the Illumina reads differed from the consensus of the original genotyping and the assembly at a
single locus; the assemblies indicated these all corresponded to a single ST, suggesting a rare systematic
error. In four cases, the STs inferred from the assembly and Illumina reads differed at a single locus, and
the original genotyping data were missing or inconsistent with both.
The wider ‘core’ genome was deﬁned as a set of 1,194 COGs, a single representative of which was
found in each genome19. Independent re-analysis of this dataset with a different method for deﬁning
COGs found 1,206 ‘core’ COGs, of which 1,027 were identical to the 1,194 originally identiﬁed55.
Concatenated codon alignments of the ‘core’ COGs were subject to three independent analyses with
BAPS version 5, which converged on identical membership of the sixteen sequence clusters, in two cases,
with additional isolates included within SC7 in the third. The ﬁfteen sequence clusters containing similar
isolates were correspondingly monophyletic in the core genome phylogeny, conﬁrming them as being
closely related sets of bacteria (Fig. 3).
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Validation of recombination analyses
Recombination detection was only attempted within the 15 monophyletic sequence clusters, as they
consisted of groups of isolates with detectable similarity that was likely to reﬂect recent common ancestry.
Simulations indicated that the type of approach that was used to identify recombinations in whole
genome alignments is most accurate when applied to sets of closely-related sequences48. In the analyses
presented in this work, all alignments in which at least ten recombination events were detected formed an
exponential recombination length distribution with a rate constant consistent with other genomic
data23,56–58 and experimental work47. The positions of recombination ‘hotspots’ relative to the reference
genome annotations were also consistent with these independent analyses. In the cases where evidence of
a molecular clock could be detected, the substitution rate was also found to be consistent with the
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Figure 2. Validation of the draft genome assemblies. (a) Venn diagram showing the overlap between the
sequence types from the original genotyping of the collection, those inferred from Illumina sequence read
mapping, and those inferred from the genome assemblies. Only data for the 594 isolates for which all
three datatypes were available are represented here. (b) Venn diagram showing the overlap between sequence
types inferred by different methodologies, in this case treating results as being consistent if only one of the
seven loci differed between results. In this case, the sequence types inferred from read mapping and de novo
assembly are identical, and differ from the original genotyping in only twelve cases. (c) Histogram showing the
number of CDSs in publicly available annotated complete, or high quality draft, S. pneumoniae genomes.
(d) Histogram showing the number of CDSs in the 616 draft genomes from Massachusetts. This distribution
shows that the count of putative CDSs in each draft genome is within the range of CDSs identiﬁed in
manually annotated genomes, consistent with the draft genomes being near-complete, and the CDS predictions
being accurate.
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analyses of other S. pneumoniae datasets23,56–58. Additionally, the consistency of the ﬁnal phylogenies
with the epidemiological data allowed a phylogeographic signal to be detected19.
Further analysis of the isolates’ inferred serology (Table 1 (available online only)) identiﬁed cases
where closely-related isolates differed at their cps loci, suggesting ‘serotype switching’ had occurred. In all
cases where the pattern of switching could be robustly established, the change at the cps locus could be
attributed to an inferred recombination affecting the relevant genes4.
Usage Notes
Sequence data may be downloaded from the European Nucleotide Archive using the project accession
codes ERP000809 or PRJEB2632. All accession codes for raw sequence data and annotated individual
assemblies are listed in Table 1 (available online only). Associated epidemiological data was published
previously19. Sequences and functional annotation can be displayed using Artemis41. Whole genome
alignments can be viewed and analysed using standard software. Gubbins48 can be applied to them for the
inference of recombined sequence. The software for serological typing can be run on Linux or Mac OSX
as described in the accompanying README ﬁle.
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